These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Pharmacokinetics of 10-ethyl-10-deaza-aminopterin, edatrexate, given weekly for non-small-cell lung cancer. Hartley JM; Nicholson PW; Allen R; Lamond P; Harland SJ; Souhami RL Cancer Chemother Pharmacol; 1993; 31(4):328-32. PubMed ID: 8380758 [TBL] [Abstract][Full Text] [Related]
47. Biodetermination of N-(deacetyl-O-4-vinblastoyl-23)-L-tryptophan, a metabolite of vintriptol, by high-performance liquid chromatography with fluorescence detection. van Tellingen O; Beijnen JH; Baurain R; ten Bokkel Huinink WW; van der Woude HR; Nooyen WJ J Chromatogr; 1992 Feb; 574(2):293-8. PubMed ID: 1618962 [TBL] [Abstract][Full Text] [Related]
48. High-performance liquid chromatographic bio-analysis and preliminary pharmacokinetics of the experimental antitumour drug vintriptol. van Tellingen O; van der Woude HR; Beijnen JH; Rao KS; ten Bokkel Huinink WW; Nooyen WJ J Chromatogr; 1990 Aug; 529(2):329-38. PubMed ID: 2229252 [TBL] [Abstract][Full Text] [Related]
49. High-performance liquid chromatographic determination of navelbine in MO4 mouse fibrosarcoma cells and biological fluids. Van Belle SJ; De Smet M; Monsaert C; Geerts F; Storme GA; Massart DL J Chromatogr; 1992 May; 576(2):351-7. PubMed ID: 1400725 [TBL] [Abstract][Full Text] [Related]
50. High-performance liquid chromatographic determination of navelbine in human plasma and urine. Nicot G; Lachatre G; Marquet P; Bonnaud F; Vallette JP; Rocca JL J Chromatogr; 1990 Jun; 528(1):258-66. PubMed ID: 2384562 [No Abstract] [Full Text] [Related]
51. Tissue disposition, excretion and metabolism of vinblastine in mice as determined by high-performance liquid chromatography. van Tellingen O; Beijnen JH; Nooijen WJ; Bult A Cancer Chemother Pharmacol; 1993; 32(4):286-92. PubMed ID: 8324870 [TBL] [Abstract][Full Text] [Related]
52. Disposition of a murine monoclonal antibody vinca conjugate (KS1/4-DAVLB) in patients with adenocarcinomas. Schneck D; Butler F; Dugan W; Littrell D; Petersen B; Bowsher R; DeLong A; Dorrbecker S Clin Pharmacol Ther; 1990 Jan; 47(1):36-41. PubMed ID: 2295217 [TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics and metabolism of vinblastine in humans. Owellen RJ; Hartke CA; Hains FO Cancer Res; 1977 Aug; 37(8 Pt 1):2597-602. PubMed ID: 889590 [TBL] [Abstract][Full Text] [Related]
54. Determination of navelbine and desacetylnavelbine in biological fluids by high-performance liquid chromatography. Jehl F; Debs J; Herlin C; Quoix E; Gallion C; Monteil H J Chromatogr; 1990 Jan; 525(1):225-33. PubMed ID: 2338443 [No Abstract] [Full Text] [Related]
55. Determination of vinorelbine in biological fluids by high-performance liquid chromatography. Levêque D; Jehl F J Chromatogr B Biomed Appl; 1995 Oct; 672(2):314. PubMed ID: 8581141 [No Abstract] [Full Text] [Related]
56. The clinical pharmacology of mitozantrone. Smyth JF; Macpherson JS; Warrington PS; Leonard RC; Wolf CR Cancer Chemother Pharmacol; 1986; 17(2):149-52. PubMed ID: 3719894 [TBL] [Abstract][Full Text] [Related]
57. Bio-analysis of N-(deacetyl-O-4-vinblastoyl-23)-L-ethyl isoleucinate, methane sulphonate (VileE) by high-performance liquid chromatography with fluorescence detection. van Tellingen O; Beijnen JH; van der Woude HR; Baurain R; ten Bokkel Huinink WW; Nooyen WJ J Pharm Biomed Anal; 1990; 8(8-12):1029-31. PubMed ID: 2100581 [No Abstract] [Full Text] [Related]
58. High performance liquid chromatographic analysis and pharmacokinetic investigation of oxacillin and its metabolites in man. Murai Y; Nakagawa T; Yamaoka K; Uno T Chem Pharm Bull (Tokyo); 1981 Nov; 29(11):3290-7. PubMed ID: 7337930 [No Abstract] [Full Text] [Related]
59. A Pilot Study of Vinorelbine Safety and Pharmacokinetics in Patients with Varying Degrees of Liver Dysfunction. Gong J; Cho M; Gupta R; Synold TW; Frankel P; Ruel C; Fakih M; Chung V; Lim D; Chao J Oncologist; 2019 Aug; 24(8):1137-1145. PubMed ID: 30710067 [TBL] [Abstract][Full Text] [Related]
60. Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130Cas/Src inhibition by eribulin. Dybdal-Hargreaves NF; Risinger AL; Mooberry SL Oncotarget; 2018 Jan; 9(5):5545-5561. PubMed ID: 29464017 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]